First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
38.47
+1.60 (4.34%)
Jul 21, 2026, 2:06 PM EDT - Market open
TRAX Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, TRAX stock has a consensus rating of "Strong Buy" and an average price target of $43.88. The average 1-year stock price forecast is 14.06% higher than the current stock price, while the lowest is $30 (-22.02%) and the highest is $70 (+81.96%).
Price Target: $43.88 (+14.06%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 |
| Buy | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Reiterates $40 → $48 | Buy | Reiterates | $40 → $48 | +24.77% | Jul 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $54 | Buy | Maintains | $54 | +40.37% | Jul 20, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $45 | Buy | Maintains | $45 | +16.97% | Jul 10, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $31 → $30 | Buy | Reiterates | $31 → $30 | -22.02% | Jul 10, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $30 | Buy | Reiterates | $30 | -22.02% | Jul 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.60
EPS Next Year
-3.24
from -3.60
EPS and Forward PE are based on non-GAAP adjusted numbers.